THURSDAY, MAY 25, 2017

Targovax adds Aksnes, Madsen to executive management team

World-renowned cancer immunotherapy specialist Targovax recently added a pair of highly-experienced executives to leadership roles in the company in Anne-Kirsti Aksnes, Ph.D., and Tina Madsen, MSc Pharm. Read More »

Health professionals confirm 59 measles cases in California

Experts from the California Department of Public Health recently confirmed 59 measles cases in California since December 2014. Read More »

Researchers learn how mosquitoes detect humans

Researchers at the University of California at Riverside recently determined that indoor, malaria-carrying mosquitoes can detect a human’s presence by changes in carbon dioxide levels, instinctually telling the insect to begin feeding. Read More »

FDA approves meningitis vaccine Bexsero

The U.S. Food and Drug Administration said on Friday that it has approved meningitis vaccine Bexsero. Read More »

TB case confirmed in Vermont school worker

The Vermont Department of Health said last week that it recently diagnosed a school employee with tuberculosis. Read More »

HHS seeks contractors to test malaria vaccines

The U.S. Department of Health and Human Services, through the National Institutes of Health's Allergy and Infectious Diseases unit, is seeking contractor proposals for testing new malaria vaccines, the NIH said recently. Read More »

GSK sends candidate Ebola vaccine to Liberia

GSK recently announced that the shipment of the first batch of its candidate Ebola vaccine should arrive in Liberia on January 23, 2015. Read More »

Private sector commits funds to Gavi childhood immunization effort

At Gavi’s major Vaccine Alliance in Berlin, several partners from the private sector newly committed to providing childhood immunizations for developing countries. Read More »

WHO initiative delivers malarial treatment door-to-door in Sierra Leone

Two emergency response campaigns recommended by the World Health Organization (WHO) recently distributed anti-malarial drugs to more than 2.5 million people in Sierra Leone. Read More »

New study shows how to better treat staph infections

Researchers at Saint Louis University recently discovered new information regarding how antibiotics stop staph infections (staphylococcus aureus) and why staph sometimes become drug-resistant. Read More »

Cobas MRSA/SA Test gets FDA approval

The Food and Drug Administration recently issued 510(k) clearance for Roche’s cobas MRSA/SA Test, Roche said Monday Read More »

FDA names new deputy commissioner for medical products, tobacco

The Food and Drug Administration appointed Dr. Robert Califf on Monday as its deputy commissioner for medical products and tobacco. Read More »

Conafay Group VP named to LouisianaBio board

Conafay Group Vice President Gregory Davenport has been appointed to serve on the LouisianaBio statewide biotechnology trade association’s 2015-16 Board of Directors, LouisianaBio said Monday. Read More »

Georgia researchers unveil PIV5 vaccine to combat rabies

A study at the University of Georgia has discovered a new treatment on mice that can potentially cure rabies, even after the virus has spread to the brain, where it would then be fatal. Read More »

EFSA-ECDC report shows increase in listeriosis infections

Recent findings in a report from EFSA-ECDC announced that there is a rise in listeriosis infections, commonly known as food poisoning. Read More »

Antiangiogenesis drugs may advance tuberculosis treatment

Researchers have determined that antiangiogenesis drugs can improve treatments for tuberculosis (TB) as well as certain cancers. Read More »

Oxfam insists wealthy countries help Ebola-ridden areas

Oxfam is calling for a multi-million dollar post-Ebola ‘Marshall Plan’ to help out the three West Africa countries hit hardest by the crisis. Read More »

Researchers trace origin of TB strain

Scientists recently published results from a study about the origins of the mycobacterium strain responsible for tuberculosis (TB), especially the Beijing lineage, in efforts to develop better treatments and diagnoses for multidrug resistant (MDR) TB in Eurasia. Read More »

200,000 children screened for meningitis in Malawi

The Meningitis Research Foundation (MRF) recently announced that more than 200,000 children have been saved since October 2012, thanks to the MRF’s Action Meningitis intervention project. Meningitis is a serious illness that can majorly disable to kill patients in a matter of hours. Read More »

GSK-Novartis three-part transaction almost complete

Drug company GlaxoSmithKline recently received clearance from the European Commission of its proposed three-part transaction with fellow drug company Novartis. Read More »